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Abstract: Most foods are considered functional in terms of providing nutrients and energy 
to sustain daily life, but dietary systems that are capable of preventing or remediating a 
stressed or diseased state are classified as functional foods. Dry beans (Phaseolus vulgaris
L.) contain high levels of chemically diverse components (phenols, resistance starch, 
vitamins, fructooligosaccharides) that have shown to protect against such conditions as
oxidative stress, cardiovascular disease, diabetes, metabolic syndrome, and many types of 
cancer, thereby positioning this legume as an excellent functional food. Moreover, the 
United States has a rich dry bean history and is currently a top producer of dry beans in the 
world with pinto beans accounting for the vast majority. Despite these attributes, dry bean 
consumption in the US remains relatively low. Therefore, the objective of this manuscript 
is to review dry beans as an important US agricultural crop and as functional food for the 
present age with an emphasis on pinto beans.
Keywords: pinto beans; dry beans; functional food; phenolic compounds;
legumes; nutraceuticals
OPEN ACCESS
Agriculture 2013, 3 91
1. Introduction
Dry beans (Phaseolus vulgaris L.) or common beans, have been characterized as a nearly perfect 
food because of their high protein, fiber, prebiotic, vitamin B, and chemically diverse micronutrient
composition [1,2]. Dry beans can also be grown in a variety of eco-agricultural regions and distributed 
in multiple forms, such as whole unprocessed seeds, as part of mixes, canned products, or as a gluten 
free wheat flour substitute. As a result, dry beans are used throughout the world representing 
50% of the grain legumes consumed as a human food source. Alternatively, overall US intake of dry 
beans is low despite links to reduced disease risks or states prevalent in western cultures, such as 
oxidative stress, inflammation, cancer, heart disease, and metabolic syndrome [3]. Of the 14 different 
market classes grown in the US, the pinto bean account for vast majority in terms of production 
(Figure 1) and consumption [4]. Although all the market classes contain similar major components 
(protein, fat, carbohydrates, minerals), each have unique minor chemical profiles that can affect their 
functional food outcomes. Yet, dry beans are understudied with research programs remaining critically 
underfunded compared to other commodities. Therefore, the objective of this review is to provide 
information on dry beans as an important crop not only for the US agriculture sector (past and present) 
but as a potential functional food for western societies with an emphasis on pinto beans.
Figure 1. Market classes of dry beans produced (in total percent) (adapted from USDA
data [4]). (Others include small white, light red kidney, dark red kidney, lima, black-eyed,
cranberry, and pink.)
2. Agriculture Development of Dry Beans
The dry bean is truly a “new world crop” originating 7000 years ago in two different parts of the 
North and South American continents [5,6]. The clear separation of the two domestication centers,
i.e., Mesoamerica (southern Mexico and Guatemala) and regions along the Andes mountain range 
(principally Peru and Columbia), resulted in the small seeded Mesoamerican beans and the large 
seeded Andean gene pools. The Mesoamerican beans spread northward during the next several 
millennia to what is now the US, Canada, and the Caribbean Islands whereas the Andes migrated 
throughout South America to the eastern coast.
In the US, dry beans can be traced to 1300 AD, specifically in the northeast where they played an 
important role in the “three sisters” farming practices of the Native American Indians. As the middle 
sister to corn and squash, dry beans fixed nitrogen in the soil supplying fertilizer to its two sisters. 
Corn provided a trellis for the beans to grow while squash served as a cover crop preventing moisture,
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evaporation and weed pressure. The three sisters in combination provided most of the daily nutrients 
needed for a balanced diet.
It was not until the 15–16th century that dry beans crossed the Atlantic Ocean. Spanish and 
Portuguese explorers first transported dry beans to Europe and Africa, respectively, where beans then 
spread rapidly to the rest of the world [2]. Dry beans have since evolved into multiple market classes 
and are grown/consumed in most parts of the world. Currently, Brazil is the No. 1 producer growing 
on average 3.2 million metric tons (mmt) followed by India, Myanmar, and China growing ~3.0 mmt,
1.7 mmt, and 1.2 mmt, respectively, on a per annual basis [7]. The US and Mexico fluctuate between 
the 5th and 6th position producing ~1.0 mmt of dry beans per year [7].
New York was the first US state on record to grow dry beans and was the leading producer from the 
1800s until the early 1900s when Michigan assumed this position. Commercial production of dry 
beans is now scattered across 19 states with North Dakota, Michigan, Nebraska, Minnesota and Idaho 
being the leaders relative to total yields (Figure 2). These states have remained in the top five positions 
for the last decade with Nebraska and Minnesota switching in the 3rd and 4th ranking depending on 
the year. Typically, Nebraska exceeds the other top ranking states in yield per acre. According to the 
USDA 2010 statistics [8], Nebraska produced on average 910 kg/acre (2010 lbs/acre) of dry beans 
followed by Idaho (860 kg/acre, 1900 lbs/acre), Michigan (820 kg/acre, 1800 lbs/acre), and North 
Dakota (657 kg/acre, 1490 lb/acre). Pinto beans account for the largest market class produced in the 
US and are grown in most of the dry bean growing states (Figure 2) with the navy and black beans 
following a distance 2nd and 3rd [4,9,10] (Figure 1).
Figure 2. States that produce dry beans [9].
* Represents states that entered production after 1990. States with (number) represents overall 
ranking in terms of total amount of dry beans produced in 2010.
The dry bean is a staple food in Latin America, Africa, and India [11], but intake in the US and 
other western societies is substantially low in comparison. US consumption of dry beans is on average 
~6.5 lbs (2.95 kg) per person per year with pinto beans again being the top choice. Whole pinto beans
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are usually purchased as canned pre-cooked or plastic packaged dry beans and are then taken to private 
homes where they are prepared as ingredients for other foods, such as soups, casseroles, Latin 
American dishes, or salads. Approximately 75%–80% of bean consumption takes place in the home, 
while the remaining 20%–25% occurs at restaurants, as fast foods, or in cafeterias [12]. Mexican 
Americans or other Hispanics are the highest consumers of pinto beans with equal intake occurring by
men and women (31–50) regardless of ethnicity [3]. The rising Hispanic population has been credited 
with the mainstream consumption of all types of cooked beans in the US [12].
3. Composition of Dry Beans 
The compositional profile of dry beans in general, and pinto beans specifically, are included in this 
section to provide possible links to their disease protecting properties, as discussed in Section 4.
Although a critical gap in knowledge exists on these mechanisms, dry beans currently hold two 
positions on the newly developed US MyPlate nutrition guide [13]. Firstly, dry beans are grouped with 
meat, fish, eggs, nuts as a high source of protein. Dry beans supply approximately 8%–10% of the 
daily recommended allowance of protein per 100 g serving of cooked beans with methionine being the 
only absent essential amino acid. Secondly, dry beans are categorized with the vegetable group due in 
part to their high fiber content. Dry beans are also composed of several types of prebiotics, including 
resistant starch (RS) and the fructooligosaccharides, stachyose and raffinose [14]. These compounds 
serve as substrates for bacterial fermentation in the human intestine, thereby influencing the microbial 
ecology of the gastrointestinal (GI) tract and gut metabolism [15,16]. Additionally, dry beans contain 
iron and calcium at levels that respectively fulfill ~11 and 2%–6% (100 g serving) of the daily 
reference intake (DRI) for a 2000 Calorie (kcal) diet. Of the vitamins, the B vitamins are present in 
particularly high levels. One cup of beans (225 g cooked) supplies ~74% of folic acid (vitamin B9) [17].
This nutrient supports multiple biological functions, including synthesis, repair and methylation of 
DNA, and acts as a cofactor in many reactions [18]. Folic acid is needed for healthy blood cell
production to prevent anemia in children and adults [19]. In addition, one cup of beans provides ~30%
of the DRI for vitamin B6 and at least 25% of the DRI for thiamin [17]. Lastly, dry beans (100 g 
cooked) contain vitamins A and C that account for 3%–8% of the DRI. Table 1 shows the basic 
compositional profiles of the cited compounds relative to pinto beans. 
Considerable less fat-soluble nutrients are present in dry beans as total lipid levels are low 
(1%–2%). Still, the lipid fraction contains the essential vitamins, E and K. One cup of beans provides 
~11% and ~5% DRI of Vitamin E and K, respectively [17]. Vitamin E is a potent antioxidant and 
anti-inflammatory agent with the isomers -tocopherol and -tocopherol being the most abundant 
forms in dry beans [20–22]. Vitamin K intake is widely associated with bone health, but has been 
linked to anti-cancer properties [23–26]. Polyunsaturated fatty acids (PUFAs) represent another 
important lipid class of compounds present in dry beans, specifically the omega fatty acids (linoleic 
acid (n-6) (LA) and alpha linoleic acid (n-3) (ALA)) [27]. Epidemiologic studies have shown overall 
improvement in the health of individuals with coronary heart disease (CHD) when fed the alpha 
linolenic acid (n-3) (ALA) [28]. After absorption into a cell, LA is elongated and desaturated to 
arachidonic acid while ALA is elongated and desaturated into eicosapentaenoic acid (EPA) and then 
into docosahexaenoic acid (DHA). EPA and DHA are omega-3 fatty acids prevalent in fish that have 
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received intense interest due to their cardioprotective and anti-inflammatory properties [29,30].
Leukotrienes, prostaglandins, and thromboxanes, metabolic products derived from AA are generally 
pro-inflammatory and proaggregatory agonists, while those derived from the ALA are able to inhibit 
platelet aggregation and inflammation. The latter mechanisms are involved in the prevention of 
cardiovascular disease (CVD), hypertension, type 2 diabetes, chronic obstructive pulmonary disease, 
among others [31]. In particular, pinto beans contain ~0.3 grams of ALA per 100 g of raw portion [32].
The fatty acid levels present in pinto beans are shown in Table 1 based on their degree of saturation.
(The reader is referred to Winham et al. [33] for compositional information relative to other types of 
dry beans.)
Table 1. Nutritional components of raw and cooked pinto beans (USDA database [34]).
Nutrient
Value per 100 g
Raw Cooked *
Proximates
Energy 347.00 kcal 143.00 kcal
Protein 21.42 g 9.01 g
Total fat 1.23 g 0.65 g
Carbohydrate 62.55 g 26.22 g
Fiber, total dietary 15.50 g 9.00 g
Sugars, total 2.11 g 0.34 g
Minerals
Calcium (Ca) 113 mg 46 mg
Iron (Fe) 5 mg 2 mg
Magnesium (Mg) 176 mg 50 mg
Phosphorus (P) 411 mg 147 mg
Potassium (K) 1393 mg 436 mg
Sodium (Na) 12 mg 1 mg
Zinc (Zn) 2 mg 1 mg
Vitamins
Vitamin C (total ascorbic acid) 6.30 mg 0.80 mg
Thiamin 0.71 mg 0.19 mg
Riboflavin 0.21 mg 0.06 mg
Niacin 1.17 mg 0.32 mg
Vitamin B6 0.47 mg 0.23 mg
Folate, DFE 0.53 mg 0.17 mg
Vitamin E (alpha-tocopherol) 0.21 mg 0.94 mg
Vitamin K (phylloquinone) 5.6 g 3.5 g
Lipids
Fatty acids (total saturated) 0.24 g 0.12 g
Fatty acids (total monounsaturated) 0.23 g 0.13 g
Fatty acids (total polyunsaturated) 0.41 g 0.24 g
* without addition of salt.
In addition to the nutrients described previously, other phytochemicals are present in dry beans but 
at low levels (parts per million or parts per billion). Nonetheless, these phytochemicals (phenolic 
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compounds, lignins, lectins, and trypsin inhibitors) exert potent protective properties against multiple 
chronic conditions with the phenols playing a major role [35–40]. Figure 3 illustrates the different 
classes phenols based on their chemical structures. As over 8000 structurally distinct phenols have 
been identified [41], numerous quantities and combinations can arise affecting their physiochemical 
characteristics and thus their bioavailability and biological targets [42,43]. Phenolic acids are a 
subclass of the phenolic compounds that contain at least one aromatic ring and one hydroxyl group 
(Figure 3). Flavonoids are the largest subclass of polyphenols in the human diet and are characterized 
by two or more aromatic rings containing at least one hydroxyl group in each and connected with a 
heterocyclic pyran (Figure 3). Flavonoids can be sub-divided further into two main groups, 
anthocyanins (glycosylated derivative of anthocyanidin) and anthoxanthins (Figure 3). Anthoxanthins 
are composed of several categories, such as flavones, flavanones, flavonols, flavanols, isoflavones and 
their glycosides [44]. It was generally believed that the phenols exerted their health benefit by directly 
scavenging free radicals or reactive oxygen species (ROS) or chelating of redox metals, but these 
properties are now largely attributed to the phenols’ ability to act as signaling agents of cellular 
endogenous responses [36,45].
Figure 3. Classification and structure of the main polyphenols classes (adapted from [46,47]).
All plant based systems contain phenolic compounds, but these compounds are typically more 
diverse and abundant in fruits, vegetables, leaves, and seeds [48]. However, dry beans contain various 
types and quantities of phenolic compounds depending on the market class [49–53]. As such, different 
bean market classes can possess different functional food properties. Thompson et al. [52] showed that 
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cooked bean powders isolated from different market classes were able to reduce cancer tumors in rats, 
but the response differed based on the type of bean. The response did not correlate to the amount of 
total phenols present, but rather to the domestication origin of the bean suggesting that the type or 
combination of bioactive agents were as important if not more so than the quantity. Moreover, as 
secondary metabolites, phenols can be impacted by the level of stress (environment, farming practices, 
production location) potentially altering their phenolic compositional profile on a lot to lot basis [54].
The pinto bean is especially high in the phenols shown in Figure 4 and listed in Table 2 [55,56].
Additionally, dry beans contain lignin, an indigestible component that cross-links with phenolic 
compounds changing their structure and solubility [57]. Lignins have been shown to promote 
gastrointestinal health [58]. It also must be noted that dry beans are composed of anti-nutrients 
(phytates, tannins, lectins, protease, a-amylase inhibitors, saponins, among others), although many 
have been associated with human health benefits [59]. For example, phytate has been linked to 
anticancer activity [60], but it also binds cations (i.e., iron and zinc) negatively impacting mineral 
bioavailability in the intestinal lumen [61].
Figure 4. Structure of pinto based phenols (from ChEBI database [62]).
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Table 2. Main phenolic compounds present in pinto beans.
Class Subclass Content (mg/100g) Reference
Phenolic acids
p-coumaric acid 4.9 a
Luthria & Pastor-Corrales [63]
Ferulic acid 18.0 a
Sinapic acid 7.8 a
Gallic acid 8.7
Flavonols
Kaempferol 3-O-glucoside 14.8
Xu & Chang [11]
Kaempferol 3-O-acetylglucoside 3.0
a mean of three varieties.
4. Functional Food Properties of Pinto Beans: Protection against Chronic Cellular Stresses/Diseases
Chronic conditions such as diabetes, cancer, and heart disease are becoming more prevalent among 
all ages and ethnic groups throughout the US and other western societies resulting in global economic 
burdens reaching the $USD trillions [64]. A possible contributor to these debilitating diseases may lie 
in the consumption of overly processed foods and the high cereal:legume consumption ratio that has 
emerged in the US over the last 60 years. Instead of the recommended 2 cereal:1 legume ratio for 
optimal consumption, the ratio has reached 8 or 9:1. Moreover, epidemiology studies have shown 
positive links between legume (bean) rich diets, such as increased longevity [65], heart health [66,67],
and reduced risks for many types of cancers [68–72]. As the pinto bean is the most commonly 
consumed dry bean in the Americas, this section provides a brief review of the limited but seminal 
studies on the functional food properties of this market class. A summary of the discussed studies are 
also shown in Table 3.
4.1. Oxidative Stress
Reactive oxygen species (ROS) and other oxidative agents are produced by physiological and 
biochemical processes that are critical to human health. Oxidative stress occurs when the production of 
oxidants is offset by the ability of the cell to readily detoxify these agents. Elevated ROS levels can 
damage cellular lipids, proteins, and DNA, potentially leading to a variety of chronic conditions or 
diseases, including CVD and atherosclerosis, hypertension, diabetes and Alzheimer's disease [73,74].
Phenols protect against cellular oxidative caused by inflammation, microbial infection, dietary habits 
and other effects [75,76] by several possible mechanisms, including scavenging free radicals, 
inhibiting or activating redox enzymes, or acting as metal chelators [77]. The phenols are typically less 
potent than pharmaceutical drugs, but most likely exert their long-term physiological effects by their 
frequent consumption as they are widely distributed in a variety of foods. 
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Table 3. Summary of studies on pinto beans and health promotion.
Stress-disease Model Treatment Dosage Main Outcomes References
Oxidative stress 
and inflammation
In vitro (ORAC, 
COX and 150 LOX 
kits)
Hulls extracts 
from pinto and 
three types of 
beans
Pinto beans-158.20 mg/g a
of total phenols and 
3.04 mg/g of flavonols b
Total phenolic content and antioxidant activity of bean 
hulls were 6–8-fold higher than in whole beans. Extracts 
from pinto beans exhibited highest antioxidant capacity. 
Black and pinto beans exhibited the strongest COX-1 and 
COX-2 inhibitory effects. Pinto showed the strongest 
LOX inhibitory effect.
Oomah et al.
[56]
Cancer and CVD
40 men and 40 
women aged 18–55 y 
with or without pre 
MetS
cooked pinto 
beans
1/2 cup (130 g) of
beans per day for 
12 weeks
Propionate production was higher in treated groups than in 
control group. Eubacterium limosum was 50% lower in 
response bean consumption. Beans intake associated with 
lower blood total cholesterol in the controls (8%) and the 
pre-MetS group (4%). Bean consumption also resulted in 
lowered serum HDL-C and LDL-C in both groups.
Finley et al.
[16]
CVD and 
diabetes mellitus
mildly insulin
resistant adults 
(7 men, 9 women)
cooked pinto 
beans
1/2 cup of
beans daily for 8 weeks
Reduction of serum TC and LDL-C concentrations 
by over 8%.
Winham et al.
[78]
Oxidative stress 
and bone 
resorption
12-month-old male 
C57BL/6 mice
bean hull 
extract
400 or 800 mg/kg for 
3 months
BHE showed high antioxidant activity and its 
supplementation for 3 months decreased serum 
concentration of a bone resorption marker, and increased 
bone mineral density and trabecular thickness in the L3 
vertebra in mice.
Cao et al.
[77]
Colon cancer
5 week old male 
F344 rats
Cooked pinto 
beans
Adjusted with beans 
to 18 g of protein/100 g 
of diet
Carcinogen azoxymethane induced rats fed a pinto bean 
rich diet had lower colon adenocarcinoma and tumor 
multiplicity.
Hughes et al.
[69]
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Table 3. Cont.
Stress-disease Model Treatment Dosage Main outcomes References
Oxidative stress 
and cancer cell 
proliferation
Human gastric 
adenocarcinoma 
AGS cells (CAA 
assay) and 9 human 
cancer cell lines 
(anti-proliferation 
assays)
Phenolic extracts 
from dry matured 
seeds of 13 food 
legumes, including 
pinto beans
0.125, 0.25, 0.5, 1, 2, 
and 5 mg/mL of 
phenolic extract
Pinto beans, lentil and other beans exhibited 
dose-dependent inhibitory effects on cell 
proliferation of all tested cancer cell lines. 
Pinto beans showed the second strongest 
anti-proliferative activity of all analyzed 
legumes. Black soybean exhibited the greatest 
CAA with the lowest IC50 value followed by 
black bean and pinto bean.
Xu & Chang
[79]
Oxidative stress 
and inflammation
macrophage cell 
line, RAW 264.7
Protein 
hydrolysates
Negro 8025 and 
Pinto Durango 
beans
0.5–200 M (based 
on soluble protein)
Hydrolysates of both varieties inhibited 
inflammation by modulation of NF- B
pathways (reducing its transactivation and the 
nuclear translocation of p65 subunit)
Oseguera-Toledo et al.
[80]
Cardiovascular
health
Normal young men
Canned pinto 
beans
450 g/day Average reduction in cholesterol levels (10%).
Shutler et al.
[81]
Cardiovascular
health
Hyperlipidemic
men
Whole pinto beans 120–162 g/day
Average reduction in serum cholesterol levels 
(10.4%).
Anderson et al.
[82]
Blood glucose 
levels
In vitro digestibility
Pinto Bean 
Starches
Not applicable
Pinto bean digested at a slower rate compared 
to faba beans, which may be more effective in 
controlling glucose levels.
Ambigaipalan et al.
[83]
Gastrointestinal 
health
In vitro
fermentation
Polysaccharides 
from cooked pinto 
beans
Not applicable
Higher production of SCFA and 
altered pH.
Campos-Vega et al.
[84]
ORAC: oxygen radical absorbance capacity; COX: cyclooxygenase; LOX: lipooxygenase; HDL-C: High density lipoprotein-cholesterol; LDL-C: low density lipoprotein-cholesterol; 
TC: total cholesterol; BHE: bean hull extract, a milligram equivalents of (+)-catechin per gram of sample; b milligram equivalents of quercetin per gram of sample. CAA = cellular 
antioxidant activity; NF- B: nuclear factor-kappa B; SCFA = short chain fatty acids. 
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Considering their high phenol content [53,85], the pinto bean as well as other dry beans, probably 
promotes health in part via antioxidative mechanisms. Xu and Chang [79] reported that black soybean,
black bean, and pinto bean exerted the highest antioxidant capacity of the 13 legumes analyzed in the 
study. Beninger and Hosfield [49] showed that pure flavonoid (anthocyanins, quercetin glycosides, and 
proanthocyanidins) isolated from 12 different seed coats of dry beans had significant 
higher antioxidant activity compared to the Fe2+ control with the notable exception of kaempferol 
3-O-glycoside. Using a mice model, Cao et al. [77] showed that pinto bean hulls with the highest 
antioxidative activity positively impacted markers for healthy bone metabolism, i.e., such as decreased 
bone resorption. It must be noted that the antioxidant capacity of beans can be affected by processing 
or cooking. Xu and Chang [11] demonstrated that steamed pinto and black beans exerted higher 
antioxidant activities compared to those boiled in water. These results were attributed to lower losses 
of total phenols, individual anthocyanins, individual flavan-3-ols, flavonols, and total flavonols to 
the water.
4.2. Inflammation
Acute inflammation is initiated when infections or tissue damage is recognized by specific receptors 
in the body [86]. Immune cells migrate to the repair site to combat the infection and repair the 
damage [87]. During the inflammatory response, multiple chemical mediators are produced and/or 
activated, including, but limited to, interleukins (IL), nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF- B), tumor necrosis factor- (TNF- ), cyclooxygenase (COX), prostaglandin E2
(PGE2), inducible nitric oxide synthase (iNOS), and nitric oxide (NO). NF- B mediates the 
transcription of many of the pro-inflammatory mediators, including iNOS, COX-2, TNF- IL-1 ,
-6 and -8 [80–82,88–98]. However, if acute inflammation is not stopped, it can progress into 
self-perpetuating chronic inflammation that can progress into a host of diseases [88]. Chronic 
inflammation can be sustained by diet, pharmacologic substances, unresolved infections, and 
environmental pollutants. The drugs used to treat acute inflammation, such as steroidal 
anti-inflammatory drugs, have not been completely effective against the chronic inflammatory 
condition and can cause side effects, but food components including vitamins and flavonoids 
can counteract this effect [74]. Many anti-inflammatory mechanisms have been associated with 
flavonoids [91–94] (Table 4).
As such, the pinto bean may act as an effective anti-inflammatory functional food again due to its 
anti-oxidative properties [8]. Oomah, Corbe and Balasubramanian [56] analyzed four types of dry 
beans, including pinto beans, and reported that the hull extracts were able to inhibit the 
proinflammatory mediators, COX 1 and COX 2, and lipoxygenase. This effect was attributed to the 
ability of hull based phenols to stop the formation of inflammatory sustaining ROS. However, the 
antioxidant activity may not be the only means by which beans stop chronic inflammation. In another 
study using common beans, Oseguera-Toledo et al. [80] assessed the antioxidant capacity and 
anti-inflammatory properties of protein hydrolysates derived from two bean cultivars, Negro 8025 and 
Pinto Durango. More specifically, the objective of the study was to evaluate the effect of the bean 
hydrolysates on NO and PGE2 production as well as iNOS and COX-2 expression in 
lipopolysaccaride-induced RAW 264.7 macrophages. The results showed that the hydrolysates of both 
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bean varieties inhibited inflammation by modulating the NF- B pathway (reducing its transactivation 
and the nuclear translocation of p65 subunit).
Table 4. Anti-inflammatory mechanisms of flavonoids (adapted from Garcia-Lafuente et al. [91]).
Activity Mechanism Consequence
Antioxidant activity
- Radical scavenging
- ROS generation inhibition
- Pro-oxidant enzyme inhibition
Reduction of free radicals and 
lipid peroxidation
Modulation of
inflammatory cells
- Modulation of enzymatic activity
- Modulation of secretory processes
Reduction of inflammatory 
cells activation
Modulation of 
proinflammatory enzymes
- Inhibition of arachidonic acid enzymes
- Inhibition of NO synthase
Reduction of inflammatory 
mediators (NO, leukotrienes,
prostaglandins)
Modulation of 
proinflammatory 
mediators
Modulation of cytokine production
Reduction of inflammatory
cytokines (TNF- ,
interleukins)
Modulation of 
proinflammatory gene 
expression
Modulation of signal transduction
Reduction of 
proinflammatory gene 
transcription
4.3. Cardiovascular Health
Atherosclerosis is a pathogenic condition caused by accumulating lipids and fibrous compounds in 
major arteries [95] and is responsible for approximately 50% of reported fatal heart diseases, including 
CVD [96]. Atherosclerosis is diagnosed by established biomarkers, including total cholesterol (TC), 
and high ratios low density lipoprotein (LDL) to high density lipoprotein (HDL) levels. As oxidized
LDL is a significant contributing factor to atherosclerosis [55], effective treatment include those 
able to decrease LDL cholesterol (LDL-C) and/or raise HDL cholesterol (HDL-C) in 
the bloodstream.
Specific studies related to pinto beans and cardiovascular health include research completed by
Shutler et al. [81]. These researchers showed a 10% reduction in cholesterol levels of normal young males 
after ingestion of 450 g/d of canned baked beans compared to the group control. Anderson et al. [82] also 
reported a 10% reduction in serum cholesterol levels in hyperlipidemic men fed 120–162 g/d of pinto 
beans. Other studies that show the positive effects of pinto beans in reducing CVD risk factors on pre 
metaboloic syndrome subjects are presented in Section 4.4.
Resistant starch is a component of pinto beans that may be partly responsible for the cited effects.
The link between RS and blood lipid profiles lies in the production of the short chain fatty acids
(SCFA) via RS fermentation by microbes present in the large intestine. In particular, propionate
produced by RS fermentation has been correlated with lower blood cholesterol [97]. Furthermore,
overall higher levels of SCFA resulting from RS fermentation are a plausible protective property
provided by dry bean consumption against CVD [16]. Additionally, beans contain high polyphenols
that have shown to protect LDL against oxidation and decrease the uptake and degradation of
cell-modified LDL by macrophages [74].
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4.4. Metabolic Syndrome
Metabolic syndrome (MetS) is a cluster of metabolic conditions that represent risks for CVD, and 
Type 2 diabetes [98]. Specific markers of MetS include excess of central adiposity, increased serum 
triglycerides and LDL-C, lower HDL-C, higher serum glucose, and high blood pressure [16].
Accordingly, pinto beans may protect against MetS symptoms due to the high levels of unabsorbed 
carbohydrates [7]. For example, the consumption of RS may prevent or remediate MetS by acting on 
multiple biological targets, such as delaying the delivery of glucose by prolonging tissue absorption, 
modulating fat utilization, and controlling appetite through increased satiety [99,100]. SCFAs 
produced from RS fermentation in the GI tract may also alter metabolic pathways affecting blood 
lipids profiles by inhibiting cholesterol synthesis in the liver or by altering cholesterol usage from the 
plasma to the liver. Cholesterol synthesis can be suppressed by metabolizing propionate in the 
liver [100]. Also, GI bacteria can bind bile acids to cholesterol leading to the excretion of bile 
acid–cholesterol complexes through the feces. Reduced bile acid recycling by the enterohepatic
circulation results in cholesterol uptake into the liver for the biosynthesis of bile acids, thereby 
lowering cholesterol levels and the risk of CVD [101].
Studies cited in Section 4.3 showed the potential of beans in lowering cholesterol levels albeit the 
subjects were not diagnosed with MetS [81,82]. Alternatively, Finley, Burrell and Reeves [16]
determined that human subjects with or without pre-MetS fed 1/2 cup (130 g) of cooked dried pinto
beans per day for 12 weeks resulted in different serum lipid profiles. Both groups presented lower
serum HDL-C and LDL-C and lower serum total cholesterol, i.e., 8% for the control and 4% for the
pre-MetS group control. Also, propionate production was higher in the group fed the pinto beans than
the control group. In another study, Winham, Hutchins and Johnston [78] determined whether pinto
beans and black eyed peas were able modulate biochemical markers of CVD and diabetes mellitus
risks in moderately insulin resistant participants. The results showed decreased serum TC and LDL-C
concentrations by over 8% after only 8 weeks of pinto bean consumption. Another study revealed that 
pinto and black bean starches were able to modulate blood glucose levels more effectively than faba 
bean starches [83].
Lastly, reduced carbohydrate hydrolysis caused by amylase inhibition can lead to lower
postprandial glucose and insulin levels [102]. As in all dry beans, -amylase inhibitors are high in
pinto beans, but the activity is easily destroyed by typical cooking methods [103,104]. Lastly, foods
containing low glycemic index carbohydrates, such as pinto beans, may aid in the management of
MetS related abnormalities. Such foods are able to moderate blood glucose, blood insulin, and body
weight [105], albeit more studies are needed to provide a direct link to pinto beans. Nonetheless, the
current studies show the potential of pinto beans as functional food that protects against MetS.
4.5. Cancer
Cancer is a leading cause of death in the US, second only to heart disease, [106], but an estimated 
one-third of cancer deaths are related to lifestyle that include diet factors [107]. Diets rich in dry beans 
have been associated with lower risk for cancer as evidenced by several reports but again pinto beans 
were not typically used [108,109]. One such study showed that laboratory animals fed black or navy 
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beans presented with a 50% reduced incidence and number of colon tumors [68]. In another study 
using pinto bean [69], rats exposed to the carcinogen azoxymethane (AOM) but fed a bean 
supplemented diet presented with significantly lower colon cancer compared to the control. In addition 
Xu and Chang [79] compared the proliferation of nine different cancer cell lines in response to 
commonly consumed food legumes. The results showed that pinto bean and other type of legumes
exhibited a dose-dependent anti-proliferation effect on all the cancer cell lines tested. Importantly, 
pinto beans presented the second strongest anti-proliferative activity of all analyzed legumes.
The anticancer activity of beans has been mainly attributed to their polyphenolic 
compounds [60,68,79]. As stated previously, polyphenols are able to protect lipids, proteins, and 
nucleic acids from ROS that if left unchecked can predispose an individual to cancer [110].
Polyphenols intake has been associated with lower leukocyte immobilization, apoptosis induction, cell 
proliferation and angiogenesis inhibition [110,111]. Also discussed previously, pinto beans contain 
high levels of RS that act as substrates for bacterial fermentation that also results in the generation 
SCFAs [112]. It is the production of these SCFAs that provide the anti-cancer protection, particularly 
butyrate [113,114]. This SCFA has been associated with growth arrest, apoptosis, and differentiation 
in several colon cancer cell lines [114].
4.6. Gastrointestinal Health
The symbiotic relationship between human health and the GI environment is currently garnering 
intense research with diet playing a major role [115–118]. In this capacity, starch and dietary fiber, and
the nonstarch polysaccharides (soluble and insoluble, pectins, gums, hemicelluloses, inulin, fructans, 
stachyose and raffinose) present in pinto beans may impact the GI tract by positively influencing the 
microbiome and/or its fermentable products [119]. Finley, Burrell and Reeves [16] monitored the 
resident GI microbiota and SCFA levels in human subjects fed a pinto bean fiber. Although a specific 
bacterial population was not affected, subjects who consumed the pinto bean flour presented with 
higher propionate levels compared to the control group who were fed a non-bean soup. Other studies 
have shown that only minor changes in the GI propionate levels result in lower total cholesterol
levels [119,120]. In another study, higher butyrate levels were measured in the hindgut of rats fed a 
diet supplemented with beans, albeit with red kidney [121]. Considering that the fiber composition 
between beans classes are similar, comparable results are expected with pinto beans. As noted above, 
butyrate has been linked to lower risks for cancer [112–114]. Lastly, Campos-Vega et al. [84]
monitored the production of SCFA generated during the in vitro fermentation of polysaccharides 
obtained from four cooked common bean cultivars, including pinto beans. These results suggest that 
the dry beans are able to protect the colon by positively altering pH over both short (6 h) and 
prolonged (24 h) fermentation or transit periods.
5. Conclusions
Dry beans are an important US agricultural crop with our country being a top world-wide producer 
and distributor, particularly of pinto beans. Moreover, dry beans are an important source of numerous 
nutrients and phytochemicals that protect against multiple diseases currently afflicting western cultures.
Despite their importance, bean consumption is low in the US. This review therefore provides 
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information on dry beans, with an emphasis on the pinto bean, from a historical context, current 
production and consumption patterns in the United States, their chemical composition, and links to 
human health benefits. Although our understanding of the latter attributes are increasing, critical gaps 
in knowledge still remain on the role that pinto beans as any dry beans play in protecting against 
multiple disease risks or states. As dry beans contain multiple nutrients and other phytochemicals they 
most likely exert these effects as synergists or additives within the complex bean system, but again 
research remains limited in this area. Such studies are particularly important considering that dry beans 
are consumed primarily as whole products or parts of the product while cooking practices can affect 
their compositional profiles, both chemically and physically, as can the market class, lines, production 
location, etc. However, the existing studies show the potential of pinto beans and other dry bean 
market classes as a highly effective functional food capable of providing multiple health benefits.
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